title: [Study on safety and efficacy of concentrated potassium chloride infusions in critically ill patients with hypokalemia].
abstract: OBJECTIVE
  To explore the safety and clinical efficacy of intravenous infusion of concentrated potassium chloride using micro-pumps in critically ill patients with hypokalemia.
  
  
  METHODS
  One hundred and twenty-eight critically ill patients with hypokalemia, the endogenous creatinine clearance rate over 0.5 ml/second and the urine output over 50 ml/hour were randomly divided into the therapy group (n=64) and the control group (n=64). Patients in therapy group received 1,208 mmol/L (9%) KCl, while those in the control group received 201 mmol/L (1.5%) potassium chloride, intravenously with the aid of a micro-pump, with hourly equal quantity of KCl in both groups. Patients in both groups were monitored strictly, and the potassium infusion was stopped whenever the serum potassium exceeded or equal to 3.5 mmol/L.
  
  
  RESULTS
  It took (15.55+/-3.22) hours and (14.18+/-4.93) hours for the therapy group and the control group to correct the hypokalemia respectively, and there was no significant difference (P>0.05). Potassium infusion brought larger amount of fluid in the control group than the therapy group [(124.36+/-25.79) ml vs. (680.83+/-236.70) ml, P<0.01]. All patients tolerated the infusion without evidence of hemodynamic change, hyperkalemia or acute heart dysfunction. For all the patients, renal function did not throw significant influence on the potassium infusion time. An inverse correlation was observed between preinfusion potassium concentration and the quantity of potassium infused (r= -0.259, P<0.01).
  
  
  CONCLUSIONS
  Under meticulous monitoring, it is safe and effective to infuse concentrated potassium for the critically ill patients with hypokalemia. This strategy can also be followed in patients with mild renal dysfunction but without oliguria or anuria under careful monitoring.
authors.affiliation: Department of Intensive Care Unit, Beijing Hospital, Ministry of Health, Beijing 100730, China. heqing@medmail.com.cn
authors.forename: Qing
authors.initials: Q
authors.lastname: He
authors.forename: Jing-hua
authors.initials: JH
authors.lastname: Wang
authors.forename: Ya-lin
authors.initials: YL
authors.lastname: Liu
authors.forename: Pu-xian
authors.initials: PX
authors.lastname: Tang
authors.forename: Zhi-gang
authors.initials: ZG
authors.lastname: Chang
authors.forename: Li-qing
authors.initials: LQ
authors.lastname: Du
authors.forename: Xiu-feng
authors.initials: XF
authors.lastname: Huang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016638:Critical Illness; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000188:drug therapy*; D007260:Infusion Pumps; D008297:Male; D008875:Middle Aged; D011189:Potassium Chloride / Q000008:administration & dosage* / Q000627:therapeutic use; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D011189:Potassium Chloride